Mårten Fernö

Researcher
More filtering options
  1. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  2. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  3. Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat

    Andersson, C., M L Lydrup, M Fernö, Idvall, I., Gustafsson, J-Å. & B O Nilsson, 2001 May, In : Journal of Endocrinology. 169, 2, p. 241-247 7 p.

    Research output: Contribution to journalArticle

  4. Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry

    Bo Baldetorp, Mårten Fernö, Fallenius, A., Fallenius-Vecchi, G., Idvall, I., Håkan Olsson, Sigurdsson, H., Åkerman, M. & Dick Killander, 1992, In : Cytometry. 13, 6, p. 577-585

    Research output: Contribution to journalArticle

  5. Reproducibility in DNA flow cytometric analysis of breast cancer: comparison of 12 laboratories' results for 67 sample homogenates

    Bo Baldetorp, Pär-Ola Bendahl, Mårten Fernö, Alanen, K., Delle, U., Falkmer, U., Hansson-Aggesjö, B., Hockenström, T., Lindgren, A., Mossberg, L., Nordling, S., Sigurdsson, H., Stål, O. & Visakorpi, T., 1995, In : Cytometry. 22, 2, p. 115-127

    Research output: Contribution to journalArticle

  6. Different calculation methods for flow cytometric S-phase fraction: prognostic implications in breast cancer? The Swedish Society of Cancer Study Group

    Bo Baldetorp, Stal, O., Ahrens, O., Cornelisse, C., Corver, W., Falkmer, U. & Mårten Fernö, 1998, In : Cytometry. 33, 4, p. 385-393

    Research output: Contribution to journalArticle

  7. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.

    Berglund, P., Stighall, M., Karin Jirström, Rydén, L., Mårten Fernö, Nordenskjold, B. & Landberg, G., 2008, In : Journal of Clinical Pathology. 61, p. 184-191

    Research output: Contribution to journalArticle

  8. Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial

    Bjohle, J., Bergqvist, J., Gronowitz, J. S., Johansson, H., Carlsson, L., Einbeigi, Z., Linderholm, B., Niklas Loman, Malmberg, M., Söderberg, M., Sundquist, M., Walz, T. M., Mårten Fernö, Bergh, J. & Hatschek, T., 2013, In : Breast Cancer Research and Treatment. 139, 3, p. 751-758

    Research output: Contribution to journalArticle

  9. Histologic grading in breast cancer--reproducibility between seven pathologic departments. South Sweden Breast Cancer Group

    Boiesen, P., Pär-Ola Bendahl, Anagnostaki, L., Domanski, H., Holm, E., Idvall, I., Johansson, S., Ljungberg, O., Anita Ringberg, Ostberg, G. & Mårten Fernö, 2000, In : Acta Oncologica. 39, 1, p. 41-45

    Research output: Contribution to journalArticle

  10. ERBB2 amplification in breast cancer with a high rate of proliferation

    Åke Borg, Bo Baldetorp, Mårten Fernö, Dick Killander, Håkan Olsson & Sigurdsson, H., 1991, In : Oncogene. 6, 1, p. 137-143

    Research output: Contribution to journalArticle

  11. Predicting the future of breast cancer.

    Åke Borg, Mårten Fernö & Peterson, C., 2003, In : Nature Medicine. 9, 1, p. 16-18

    Research output: Contribution to journalLetter

  12. Association of int2/hst1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis

    A. Borg, Sigurdsson, H., Clark, G. M., M. Ferno, Fuqua, S. A. W., H. Olsson, D. Killander & McGurie, W. L., 1991 Jan 1, In : British Journal of Cancer. 63, 1, p. 136-142

    Research output: Contribution to journalArticle

  13. Loss of TGFβ Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance.

    Busch, S., Sims, A. H., Stal, O., Mårten Fernö & Landberg, G., 2015, In : Cancer Research. 75, 7, p. 1457-1469

    Research output: Contribution to journalArticle

  14. Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.

    Carlsson, A., Christer Wingren, Ingvarsson, J., Ellmark, P., Bo Baldetorp, Mårten Fernö, Håkan Olsson & Carl Borrebaeck, 2008, In : European Journal of Cancer. 44, 3, p. 472-480

    Research output: Contribution to journalArticle

  15. Galectin-1-binding glycoforms of haptoglobin with altered intracellular trafficking, and increase in metastatic breast cancer patients.

    Carlsson, M., Cederfur, C., Schaar, V., Balog, C. I. A., Lepur, A., Touret, F., Salomonsson, E., Deelder, A. M., Mårten Fernö, Håkan Olsson, Wuhrer, M. & Hakon Leffler, 2011, In : PLoS ONE. 6, 10, e26560.

    Research output: Contribution to journalArticle

  16. Molecular serum portraits in patients with primary breast cancer predict the development of distant metastases.

    Carlsson, A., Christer Wingren, Nordström, M., Carsten Rose, Mårten Fernö, Håkan Olsson, Jernstöm, H., Sara Ek, Gustavsson, E., Christian Ingvar, Mattias Ohlsson, Peterson, C. & Carl Borrebaeck, 2011, In : Proceedings of the National Academy of Sciences. 108, 34, p. 14252-14257

    Research output: Contribution to journalArticle

  17. Antibody microarray based oncoproteomics - analysis of breast cancer proteomes

    Carlsson, A., Christer Wingren, Ingvarsson, J., Ellmark, P., Bo Baldetorp, Mårten Fernö, Håkan Olsson & Carl Borrebaeck, 2007, In : Proceedings of the PEPTALK 2007 meeting.

    Research output: Contribution to journalPublished meeting abstract

  18. Serum protein profiling of metastatic breast cancer

    Carlsson, A., Christer Wingren, Ingvarsson, J., Ellmark, P., Bo Baldetorp, Mårten Fernö, Håkan Olsson & Carl Borrebaeck, 2007, In : Molecular & Cellular Proteomics. October, p. S311

    Research output: Contribution to journalPublished meeting abstract

  19. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?

    Choong, P. F., Åkerman, M., Willen, H., Andersson, C., Gustafson, P., Bo Baldetorp, Mårten Fernö, Thor Alvegård & Anders Rydholm, 1994, In : APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 102, 12, p. 915-924

    Research output: Contribution to journalArticle

  20. DNA ploidy in soft tissue sarcoma: Comparison of flow and image cytometry with clinical follow-up in 93 patients

    Dreinhofer, KE., Bo Baldetorp, Åkerman, M., Mårten Fernö, Anders Rydholm & Pelle Gustafson, 2002, In : Cytometry. 50, 1, p. 19-24

    Research output: Contribution to journalArticle

  21. Quality of up to 35 years old archival breast cancer tissue in paraffinblocks for estrogen receptor evaluation

    Anna Ehinger, Lisa Rydén, Pär-Ola Bendahl, Mårten Fernö & Alkner, S., 2017 Sep 2, In : Virchows Archiv. 471, Suppl. 1, p. 54 1 p., PS-01-016.

    Research output: Contribution to journalPublished meeting abstract

Previous 1 2 3 4 5 Next